• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
The 'Press Releases' section offers the latest product-specific and company-related updates to our esteemed clients, providing them with a valuable resource. Members can leverage this platform for quick, efficient, and effective visibility.

— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.
ChromaTan’s BioRMB

Chromatography Into HIP-Vax® Manufacturing Platform for AAV

ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce an alliance with Batavia Biosciences, a leading contract development and manufacturing organization, for the development and integration of ChromaTan’s BioRMBTM continuous counter-current elution technology into Batavia’s AAV HIP-Vax® manufacturing platform.

Read more →

NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients

Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets based on positive CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded LDL-C lowering in both primary and secondary prevention patients.

Read more →

SK bioscience Exports Influenza Vaccine to Thailand

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced  that the company has shipped approximately 440,000 doses of SKYCellflu® to Biogenetech in Thailand from its vaccine manufacturing facility 'L HOUSE' in Andong, South Korea. 

Read more →
Entourage Liquid Fusionner™ - Night Use

Brazilian Entrepreneur Entourage Phytolab on One Lavi

Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, announces its launch on One Lavi. Known for its commitment to quality and innovation, Entourage Phytolab is set to bring its Entourage Liquid Fusionner™ – Night Use product to the leading online platform for health, beauty, and wellness products.

Read more →
Furosemide for Injection

Avenacy Announces Launch of Furosemide for Injection

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, announced it has launched Furosemide for Injection in the United States as a therapeutic equivalent generic for Lasix® for Injection (furosemide) approved by the U.S. Food and Drug Administration.

Read more →

LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis

Mirum Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LIVMARLI® (maralixibat) oral solution for the treatment of cholestatic pruritus in patients five years of age and older with progressive familial intrahepatic cholestasis (PFIC).

Read more →
CellFX nsPFA Percutaneous Electrode System

Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System

Pulse Biosciences, Inc. a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel CellFX nsPFA Percutaneous Electrode System for use in the ablation of soft tissue in percutaneous and intraoperative surgical procedures.

Read more →